Algorithm-Based Approach to the Histological Routine Diagnosis of Renal Oncocytic Tumors in Core Biopsy Specimens.

Chromophobe renal cell carcinoma Core biopsy Differential diagnosis Immunohistochemistry Oncocytic tumor Oncocytoma

Journal

Current urology reports
ISSN: 1534-6285
Titre abrégé: Curr Urol Rep
Pays: United States
ID NLM: 100900943

Informations de publication

Date de publication:
Nov 2022
Historique:
accepted: 11 07 2022
pubmed: 29 9 2022
medline: 15 12 2022
entrez: 28 9 2022
Statut: ppublish

Résumé

A growing number of tumor entities with badly defined limits are enlarging in the last years the family of oncocytic tumors in the kidney. Chromophobe renal cell carcinoma (ChRCC) and renal oncocytoma (RO) are classically well-known tumors, but the borderland between them, and their precise connection, remains a matter of debate. Aside from that, other emerging and provisional entities, like eosinophilic solid and cystic renal cell carcinoma (ESC RCC), eosinophilic vacuolated tumor (EVT), low-grade oncocytic tumor (LOT), and papillary renal neoplasm with reverse polarity (PRRP), have been recently described. This spectrum of tumors remains a diagnostic challenge in renal pathology, especially if the specimen obtained is scarce. This review focuses on practical diagnostic problems when managing core biopsies and proposes a diagnostic algorithm maximizing the information provided by both morphology and immunohistochemistry. So, a combination of morphologic features on hematoxylin-eosin and six antibodies (CK7, CD117, CK20, CD10, GATA-3, and cathepsin K) is advised to be used in a stepwise fashion.

Identifiants

pubmed: 36169870
doi: 10.1007/s11934-022-01114-9
pii: 10.1007/s11934-022-01114-9
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

327-333

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Auteurs

Claudia Manini (C)

Department of Pathology, San Giovanni Bosco Hospital, 10154, Turin, Italy.
Department of Sciences of Public Health and Pediatrics, University of Turin, 10124, Turin, Italy.

Igone Imaz (I)

Department of Pathology, Cruces University Hospital, 48903, Barakaldo, Spain.

Aitor Fernández de Larrinoa (AF)

Department of Pathology, Cruces University Hospital, 48903, Barakaldo, Spain.

José I López (JI)

Biomarkers in Cancer Unit, Biocruces-Bizkaia Health Research Institute, Plaza de Cruces s/n, 48903, Barakaldo, Bizkaia, Spain. jilpath@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH